[go: up one dir, main page]

Skip to main content
Log in

The effect of cyclin D1 overexpression in human head and neck cancer cells

  • Head and Neck Oncology
  • Published:
European Archives of Oto-Rhino-Laryngology and Head & Neck Aims and scope Submit manuscript

Abstract

Overexpression of cyclin D1 in head and neck cancer has been suggested to be a poor prognostic factor. To understand the role of cyclin D1 expression in head and neck cancer, we overexpressed cyclin D1 in TU182 (a cell line derived from pharyngeal cancer) using a retroviral vector. Stable transfectants were isolated by neomycin (G418) selection. Compared to the parental and control-vector transfected cells, the cyclin D1 transfected cells revealed a decrease of the G1/G0 population and resulted in continuous proliferation under low serum conditions. Proliferation assays revealed an increase in resistance to cisplatin in cyclin D1 overexpressing cells. These observation suggest that deregulation of cyclin D1 may reduce growth factor requirements and contribute to the resistance to some chemotherapeutic agents among head and neck cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3 A

Similar content being viewed by others

References

  1. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG (1994) PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74:152–158

    CAS  PubMed  Google Scholar 

  2. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM, Pignataro L (2000) Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 22:234–240

    Article  CAS  PubMed  Google Scholar 

  3. Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, El-Naggar A, Hong WK, Hittelman WN (1998) Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene 17:2313–2322

    Google Scholar 

  4. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.Cancer Res 54:4813–4817

    CAS  PubMed  Google Scholar 

  5. Kornmann M, Danenberg KD, Arber N, Beger HG, Danenberg PV, Korc M (1999) Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res 59:3505–3511

    CAS  PubMed  Google Scholar 

  6. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL (1994) Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54:3662–3667

    CAS  PubMed  Google Scholar 

  7. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S (1996) Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 78:390–395

    Article  CAS  PubMed  Google Scholar 

  8. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975–978

    CAS  PubMed  Google Scholar 

  9. Nakashima T, Clayman GL (2000) Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 126:957–961

    CAS  PubMed  Google Scholar 

  10. Sherr CJ (1993) Mammalian G1 cyclins. Cel. 73:1059-1065

    Google Scholar 

  11. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551–555

    Article  CAS  PubMed  Google Scholar 

  12. Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60:3689–3695

    CAS  PubMed  Google Scholar 

  13. Rousseau A, Lim MS, Lin Z, Jordan RC (2001) Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol 37:268–275

    Article  CAS  PubMed  Google Scholar 

  14. Wang MB, Yip HT, Srivatsan ES (2001) Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Laryngoscope 111:982–988

    CAS  PubMed  Google Scholar 

  15. Zwijsen RM, Klompmaker R, Wientjens EB, Kristel PM, van der Burg B, Michalides RJ (1996) Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol 16:2554–2560

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Torahiko Nakashima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakashima, T., Kuratomi, Y., Yasumatsu, R. et al. The effect of cyclin D1 overexpression in human head and neck cancer cells. Eur Arch Otorhinolaryngol 262, 379–383 (2005). https://doi.org/10.1007/s00405-004-0831-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-004-0831-z

Keywords

Navigation